Dempsey James F.
Chief Scientific Officer at ViewRay, Inc.
- Sold, on record
- $2M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Mar 3, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ViewRay, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ViewRay, Inc.UnusualMar 14, 2018 2018
Sold 75,243 shares at $7.57 ($570k)
Dempsey James F., Chief Scientific Officer
Sold 29.2% of holdings ($2M position)182,602 shares leftFirst sale on recordFiling
- 2 Form 4 sale ViewRay, Inc.Plan not statedJul 1, 2019 +474 days
Sold 5,146 shares at $8.63 ($44k)
Dempsey James F., Chief Scientific Officer
Sold 1.6% of holdings ($2.8M position)317,498 shares leftFiling
- 3 Form 4 sale ViewRay, Inc.Plan not statedAug 1, 2019 +31 days
Sold 21,615 shares at $8.97 ($194k)
Dempsey James F., Chief Scientific Officer
Sold 8.9% of holdings ($2.2M position)220,973 shares leftFiling
- 4 Form 4 sale ViewRay, Inc.UnusualSep 3, 2019 +33 days
Sold 279,414 shares at $3.57 ($998k)
Dempsey James F., Chief Scientific Officer
Sold 55.8% of holdings ($1.8M position)220,973 shares left12.9x usual sizeFiling
- 5 Form 4 sale ViewRay, Inc.No planMar 3, 2023 +1277 days
Sold 42,000 shares at $4.13 ($173k)
Dempsey James F., Chief Scientific Officer
No 10b5-1 planSold 6% of holdings ($2.9M position)654,368 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2023 | Mar 21, 2023 | ViewRay, Inc. | Chief Scientific Officer | Form 4 sale | 42,000 | $173k | 6.0% | No plan | SEC |
| Sep 3, 2019 | Sep 4, 2019 | ViewRay, Inc. | Chief Scientific Officer | Form 4 sale | 279,414 | $998k | 55.8% | Unusual | SEC |
| Aug 1, 2019 | Aug 2, 2019 | ViewRay, Inc. | Chief Scientific Officer | Form 4 sale | 21,615 | $194k | 8.9% | Plan not stated | SEC |
| Jul 1, 2019 | Jul 2, 2019 | ViewRay, Inc. | Chief Scientific Officer | Form 4 sale | 5,146 | $44k | 1.6% | Plan not stated | SEC |
| Mar 14, 2018 | Mar 16, 2018 | ViewRay, Inc. | Chief Scientific Officer | Form 4 sale | 75,243 | $570k | 29.2% | Unusual | SEC |